These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 22805467

  • 1. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.
    Thyagarajan A, Jones SM, Calatroni A, Pons L, Kulis M, Woo CS, Kamalakannan M, Vickery BP, Scurlock AM, Wesley Burks A, Shreffler WG.
    Clin Exp Allergy; 2012 Aug; 42(8):1197-205. PubMed ID: 22805467
    [Abstract] [Full Text] [Related]

  • 2. Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness.
    Orgel K, Burk C, Smeekens J, Suber J, Hardy L, Guo R, Burks AW, Kulis M.
    Clin Exp Allergy; 2019 Apr; 49(4):461-470. PubMed ID: 30383313
    [Abstract] [Full Text] [Related]

  • 3. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
    Patil SU, Steinbrecher J, Calatroni A, Smith N, Ma A, Ruiter B, Virkud Y, Schneider M, Shreffler WG.
    J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
    [Abstract] [Full Text] [Related]

  • 4. Suppression of the immunologic response to peanut during immunotherapy is often transient.
    Gorelik M, Narisety SD, Guerrerio AL, Chichester KL, Keet CA, Bieneman AP, Hamilton RG, Wood RA, Schroeder JT, Frischmeyer-Guerrerio PA.
    J Allergy Clin Immunol; 2015 May; 135(5):1283-92. PubMed ID: 25542883
    [Abstract] [Full Text] [Related]

  • 5. Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.
    Tsai M, Mukai K, Chinthrajah RS, Nadeau KC, Galli SJ.
    J Allergy Clin Immunol; 2020 Mar; 145(3):885-896.e6. PubMed ID: 31805311
    [Abstract] [Full Text] [Related]

  • 6. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A.
    Cochrane Database Syst Rev; 2012 Sep 12; 2012(9):CD009014. PubMed ID: 22972130
    [Abstract] [Full Text] [Related]

  • 7. Functional analysis of cross-reactive immunoglobulin E antibodies: peanut-specific immunoglobulin E sensitizes basophils to tree nut allergens.
    de Leon MP, Drew AC, Glaspole IN, Suphioglu C, Rolland JM, O'Hehir RE.
    Clin Exp Allergy; 2005 Aug 12; 35(8):1056-64. PubMed ID: 16120088
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy and immune regulation with peanut oral immunotherapy.
    Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, Shreffler WG, Steele P, Henry KA, Adair M, Francis JM, Durham S, Vickery BP, Zhong X, Burks AW.
    J Allergy Clin Immunol; 2009 Aug 12; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
    [Abstract] [Full Text] [Related]

  • 9. Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapy.
    Kulis MD, Smeekens JM, Burk C, Yue X, Guo R, Orgel KA, Ye P, Herlihy L, Hamilton D, Li Q, Keet C, Shreffler W, Vickery BP, Burks AW, Kim EH.
    J Allergy Clin Immunol; 2022 Nov 12; 150(5):1144-1153. PubMed ID: 35716952
    [Abstract] [Full Text] [Related]

  • 10. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.
    Santos AF, Du Toit G, Douiri A, Radulovic S, Stephens A, Turcanu V, Lack G.
    J Allergy Clin Immunol; 2015 Jan 12; 135(1):179-86. PubMed ID: 25567046
    [Abstract] [Full Text] [Related]

  • 11. High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children.
    Kulis M, Yue X, Guo R, Zhang H, Orgel K, Ye P, Li Q, Liu Y, Kim E, Burks AW, Vickery BP.
    Clin Exp Allergy; 2019 Feb 12; 49(2):180-189. PubMed ID: 30126028
    [Abstract] [Full Text] [Related]

  • 12. Basophil activation tests for the diagnosis of food allergy in children.
    Ocmant A, Mulier S, Hanssens L, Goldman M, Casimir G, Mascart F, Schandené L.
    Clin Exp Allergy; 2009 Aug 12; 39(8):1234-45. PubMed ID: 19549026
    [Abstract] [Full Text] [Related]

  • 13. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.
    Wisniewski JA, Commins SP, Agrawal R, Hulse KE, Yu MD, Cronin J, Heymann PW, Pomes A, Platts-Mills TA, Workman L, Woodfolk JA.
    Clin Exp Allergy; 2015 Jul 12; 45(7):1201-13. PubMed ID: 25823600
    [Abstract] [Full Text] [Related]

  • 14. Oral immunotherapy with low allergenic hydrolysed egg in egg allergic children.
    Giavi S, Vissers YM, Muraro A, Lauener R, Konstantinopoulos AP, Mercenier A, Wermeille A, Lazzarotto F, Frei R, Bonaguro R, Summermatter S, Nutten S, Papadopoulos NG.
    Allergy; 2016 Nov 12; 71(11):1575-1584. PubMed ID: 27059671
    [Abstract] [Full Text] [Related]

  • 15. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P, Orsini F, Lozinsky AC, Gold M, O'Sullivan MD, Quinn P, Lloyd M, Ashley SE, Pitkin S, Axelrad C, Metcalfe JR, Su EL, Tey D, Robinson MN, Allen KJ, Prescott SL, Galvin AD, Tang MLK, PPOIT-003 study group.
    Lancet Child Adolesc Health; 2022 Mar 12; 6(3):171-184. PubMed ID: 35123664
    [Abstract] [Full Text] [Related]

  • 16. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).
    Syed A, Garcia MA, Lyu SC, Bucayu R, Kohli A, Ishida S, Berglund JP, Tsai M, Maecker H, O'Riordan G, Galli SJ, Nadeau KC.
    J Allergy Clin Immunol; 2014 Feb 12; 133(2):500-10. PubMed ID: 24636474
    [Abstract] [Full Text] [Related]

  • 17. Peanut Oral Immunotherapy: State of the Art.
    Tang MLK, Lozinsky AC, Loke P.
    Immunol Allergy Clin North Am; 2020 Feb 12; 40(1):97-110. PubMed ID: 31761124
    [Abstract] [Full Text] [Related]

  • 18. Recombinant allergens promote expression of CD203c on basophils in sensitized individuals.
    Hauswirth AW, Natter S, Ghannadan M, Majlesi Y, Schernthaner GH, Sperr WR, Bühring HJ, Valenta R, Valent P.
    J Allergy Clin Immunol; 2002 Jul 12; 110(1):102-9. PubMed ID: 12110828
    [Abstract] [Full Text] [Related]

  • 19. Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals.
    Platz IJ, Binder M, Marxer A, Lischka G, Valent P, Bühring HJ.
    Int Arch Allergy Immunol; 2001 Dec 12; 126(4):335-42. PubMed ID: 11815741
    [Abstract] [Full Text] [Related]

  • 20. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
    Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW.
    J Allergy Clin Immunol; 2014 Feb 12; 133(2):468-75. PubMed ID: 24361082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.